00000nam 2200000za 4500 9.800062 CaOODSP 20250730101504 cr ||||||||||| 150421s2018 onc #ob f000 0 eng d 978-0-660-01962-8 CaOODSP eng n-cn--- H164-33/2018E-PDF Reporting adverse reactions to marketed health products [electronic resource] : guidance document for industry. Guidance document for industry Ottawa : Health Canada, 2018. iv, 37 p. "Effective Date: May 23, 2018." Title from cover. "Your health and safety ... our priority." "MedEffect Canada. Together we can improve health product safety." Issued also in French under title: Déclaration des effets indésirables des produits de santé commercialisés : document d'orientation à l'intention de l'industrie. Includes bibliographical references. "This guidance document provides market authorization holders (MAHs) with assistance on how to comply with the Food and Drugs Act, the Food and Drug Regulations, and the Natural Health Products Regulations with respect to reporting adverse reactions (ARs) to marketed health products"--Scope, p. 1. gccst Side effects gccst Health hazards gccst Industrial policy Canada. Health Canada. Déclaration des effets indésirables des produits de santé commercialisés (CaOODSP)9.800063 Reporting adverse reactions to marketed health products : (CaOODSP)9.953703 Guidance document for industry - reporting adverse reactions to marketed health products (CaOODSP)9.694177 PDF 849 KB https://publications.gc.ca/collections/collection_2018/sc-hc/H164-33-2018-eng.pdf Pub.: 180052